×
khaskhabar
Nov 20, 2026 11:05 am
Location
 
   राजस्थान और हरियाणा सरकार से विज्ञापनों के लिए मान्यता प्राप्त



www.khaskhabar.com | Published : 18-02-2013


Drug development has focused on the chaperone Hsp90 - heat shock protein 90 - because it plays a key role in assisting mutated proteins, making it an attractive cancer drug target.

However, the clinical efficacy of Hsp90 inhibitors has been disappointing, according to the study published in the Journal of Biological Chemistry.